WHO Suspends Approval Of TB Products From India’s Svizera Labs, Supplier Of Generic Drugs To 70 Nations

International Business Times: WHO Suspends Tuberculosis Drugs From Major Indian Supplier
“The World Health Organization (WHO) reportedly suspended its approval of all tuberculosis products made at India’s Svizera Labs citing unreliable manufacturing standards and quality management. The company is one of the largest suppliers of generic TB medicines to more than 70 countries, according to its website…” (Kondalamahanty, 3/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.